다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

BIIB

Biogen (BIIB)

Biogen Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BIIB

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/31	05:51	GlobeNewswire Inc.	Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS	NASDAQ:BIIB	Biogen Inc
2024/05/23	20:40	IH Market News	OpenAI and News Corp Seal Partnership, DuPont de Nemours Announces Division, and More News	NASDAQ:BIIB	Biogen Inc
2024/05/22	20:30	GlobeNewswire Inc.	Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences	NASDAQ:BIIB	Biogen Inc
2024/05/16	20:30	GlobeNewswire Inc.	Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis	NASDAQ:BIIB	Biogen Inc
2024/05/16	20:30	PR Newswire (US)	Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis	NASDAQ:BIIB	Biogen Inc
2024/05/15	08:33	GlobeNewswire Inc.	Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status	NASDAQ:BIIB	Biogen Inc
2024/05/15	08:30	PR Newswire (US)	Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status	NASDAQ:BIIB	Biogen Inc
2024/05/02	20:30	GlobeNewswire Inc.	Biogen Reports Progress on Corporate Responsibility Priorities	NASDAQ:BIIB	Biogen Inc
2024/04/01	08:30	PR Newswire (US)	Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA	NASDAQ:BIIB	Biogen Inc
2024/03/06	21:30	GlobeNewswire Inc.	New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene Therapy	NASDAQ:BIIB	Biogen Inc
2024/03/05	06:15	GlobeNewswire Inc.	Biogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™) 2024 Annual Meeting	NASDAQ:BIIB	Biogen Inc
2024/02/27	09:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIIB	Biogen Inc
2024/02/23	21:00	GlobeNewswire Inc.	Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP	NASDAQ:BIIB	Biogen Inc
2024/02/23	00:12	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BIIB	Biogen Inc
2024/02/22	11:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIIB	Biogen Inc
2024/02/22	11:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIIB	Biogen Inc
2024/02/22	11:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIIB	Biogen Inc
2024/02/22	11:31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIIB	Biogen Inc
2024/02/22	11:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIIB	Biogen Inc
2024/02/22	11:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIIB	Biogen Inc
2024/02/22	11:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIIB	Biogen Inc
2024/02/22	00:24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BIIB	Biogen Inc
2024/02/21	11:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIIB	Biogen Inc
2024/02/14	08:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIIB	Biogen Inc
2024/02/14	08:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIIB	Biogen Inc
2024/02/14	08:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIIB	Biogen Inc
2024/02/14	08:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIIB	Biogen Inc
2024/02/14	08:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIIB	Biogen Inc
2024/02/14	08:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIIB	Biogen Inc
2024/02/14	07:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIIB	Biogen Inc

검색 관련기사 보기:NASDAQ:BIIB

1 2 3 4 5 6 7 8 9 10 다음 >>

NLBNPIT1T3R8 20240621 17

INTESA SANPAOLO

Armac Locacao Logistica ... ON

Sentinel Protocol

Amundi Luxembourg

Bee Vectoring Technologies

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관